Zhang H, Lu W, Tang H, Chen A, Gao X, Zhu C
Medicina (Kaunas). 2025; 61(2).
PMID: 40005339
PMC: 11857502.
DOI: 10.3390/medicina61020222.
Ji X, Huang Z, Zhou C, Wang Y, Geng D, Zhang G
Cell Biol Toxicol. 2025; 41(1):38.
PMID: 39875576
PMC: 11775062.
DOI: 10.1007/s10565-024-09975-1.
Qin L, Zeng X, Qiu X, Chen X, Liu S
Front Oncol. 2024; 14:1467850.
PMID: 39691597
PMC: 11649548.
DOI: 10.3389/fonc.2024.1467850.
Mehmood R
Curr Genomics. 2024; 25(3):158-170.
PMID: 39087001
PMC: 11288162.
DOI: 10.2174/0113892029296712240405053201.
Zhang J, Tong L, Liu Y, Li X, Wang J, Lin R
Genes Dis. 2024; 11(5):101199.
PMID: 38947741
PMC: 11214295.
DOI: 10.1016/j.gendis.2023.101199.
The Role of N6-methyladenosine Modification in Gametogenesis and Embryogenesis: Impact on Fertility.
Wang Y, Yang C, Sun H, Jiang H, Zhang P, Huang Y
Genomics Proteomics Bioinformatics. 2024; 22(4).
PMID: 38937660
PMC: 11514847.
DOI: 10.1093/gpbjnl/qzae050.
Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.
Ye L, Tong X, Pan K, Shi X, Xu B, Yao X
Front Pharmacol. 2024; 15:1351929.
PMID: 38895621
PMC: 11185051.
DOI: 10.3389/fphar.2024.1351929.
Molecular insights into regulatory RNAs in the cellular machinery.
Yang S, Kim S, Yang E, Kang M, Joo J
Exp Mol Med. 2024; 56(6):1235-1249.
PMID: 38871819
PMC: 11263585.
DOI: 10.1038/s12276-024-01239-6.
RNA N6-Methyladenosine Modification in DNA Damage Response and Cancer Radiotherapy.
Wang C, Yao S, Zhang T, Sun X, Bai C, Zhou P
Int J Mol Sci. 2024; 25(5).
PMID: 38473842
PMC: 10931796.
DOI: 10.3390/ijms25052597.
RNA m6A methylation and regulatory proteins in pulmonary arterial hypertension.
Wang Z, Zhang Y, Shi J, Yan Y, Zhao L, Kou J
Hypertens Res. 2024; 47(5):1273-1287.
PMID: 38438725
DOI: 10.1038/s41440-024-01607-9.
METTL3-Mediated m6A Modification Regulates the Osteogenic Differentiation through LncRNA CUTALP in Periodontal Mesenchymal Stem Cells of Periodontitis Patients.
Chen X, Qin Y, Wang X, Lei H, Zhang X, Luo H
Stem Cells Int. 2024; 2024:3361794.
PMID: 38283119
PMC: 10817817.
DOI: 10.1155/2024/3361794.
m6A Methylation-Mediated Stabilization of LINC01106 Suppresses Bladder Cancer Progression by Regulating the miR-3148/DAB1 Axis.
Liu J, Tian C, Qiao J, Deng K, Ye X, Xiong L
Biomedicines. 2024; 12(1).
PMID: 38255219
PMC: 10813768.
DOI: 10.3390/biomedicines12010114.
CircERCC6 Positively Regulates the Induced Activation of SHF Stem Cells in Cashmere Goats via the miR-412-3p/BNC2 Axis in an mA-Dependent Manner.
Zhang Q, Fan Y, Bai M, Zhu Y, Wang Z, Shen J
Animals (Basel). 2024; 14(2).
PMID: 38254355
PMC: 10812687.
DOI: 10.3390/ani14020187.
FOXM1 Participates in Scleral Remodeling in Myopia by Upregulating APOA1 Expression Through METTL3/YTHDF2.
Xue M, Li B, Lu Y, Zhang L, Yang B, Shi L
Invest Ophthalmol Vis Sci. 2024; 65(1):19.
PMID: 38190128
PMC: 10777875.
DOI: 10.1167/iovs.65.1.19.
N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
Bao J, Xu T, Wang W, Xu H, Chen X, Xia R
Mol Cell Biochem. 2024; 479(11):3077-3089.
PMID: 38180718
DOI: 10.1007/s11010-023-04906-w.
Comprehensive analysis of m6A reader YTHDF2 prognosis, immune infiltration, and related regulatory networks in hepatocellular carcinoma.
Wang H, Cai H, Li L
Heliyon. 2024; 10(1):e23204.
PMID: 38163150
PMC: 10756983.
DOI: 10.1016/j.heliyon.2023.e23204.
The role of RNA modification in urological cancers: mechanisms and clinical potential.
Zhou X, Zhu H, Luo C, Yan Z, Zheng G, Zou X
Discov Oncol. 2023; 14(1):235.
PMID: 38117350
PMC: 10733275.
DOI: 10.1007/s12672-023-00843-8.
The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
Wen T, Li T, Xu Y, Zhang Y, Pan H, Wang Y
Cell Commun Signal. 2023; 21(1):355.
PMID: 38102645
PMC: 10722709.
DOI: 10.1186/s12964-023-01385-w.
NAT10-mediated acC modification promotes ectoderm differentiation of human embryonic stem cells via acetylating NR2F1 mRNA.
Ge J, Wang Z, Wu J
Cell Prolif. 2023; 57(4):e13577.
PMID: 38041497
PMC: 10984107.
DOI: 10.1111/cpr.13577.
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance.
Jin Y, Fan Z
Cell Prolif. 2023; 57(4):e13578.
PMID: 37961996
PMC: 10984110.
DOI: 10.1111/cpr.13578.